Nasdaq Net Change Percentage Gainers & Losers

Dow Jones10-29
GAINERS
COMPANYSYMBOLLASTCHANGEPERCENTVOLUME
------------------------------------
Monte Rosa TherapeuticsGLUE9.484.5993.8794,983,989
PROCEPT BioRoboticsPRCT91.0022.2332.335,047,392
QuantaSing Group ADRQSG3.450.7728.73270,636
nLIGHTLASR13.232.9028.071,703,769
EyePoint PharmaceuticalsEYPT12.122.6227.584,553,596
Revance TherapeuticsRVNC5.901.2025.538,945,839
Trump Media & TechDJT47.368.4121.59106,838,464
Nebius Group Cl ANBIS23.754.1821.3613,220,106
NikolaNKLA5.310.8920.1410,783,492
SoundHound AISOUN6.120.9418.1549,335,684
LOSERS
COMPANYSYMBOLLASTCHANGEPERCENTVOLUME
------------------------------------
Lixiang Education ADRLXEH3.27-0.80-19.66127,668
TMT AcquisitionTMTC9.68-1.82-15.8369,249
Defiance Dly Tgt 1.5x ShSMST5.57-0.86-13.32971,208
VeeaVEEA3.90-0.45-10.34157,758
Tevogen Bio HoldingsTVGN2.74-0.31-10.1611,246,513
Tyra BiosciencesTYRA19.89-2.04-9.301,199,702
Direxion Dly TSM Bull 2XTSMX29.99-2.79-8.51362,609
Q32 BioQTTB46.74-3.85-7.6154,073
HarrowHROW47.20-3.40-6.721,068,891
MBX BiosciencesMBX19.86-1.38-6.50163,347
Only includes stocks with a prior day close of $2 a share
or higher and at least 2,000 shares traded today.
Data are delayed at least 15 minutes.
Source: WSJ Market Data Group

(END) Dow Jones Newswires

October 28, 2024 17:42 ET (21:42 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment